References
- WHO. Corona virus disease. [cited 2022 Nov 9]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
- Najafloo R, Majidi J, Asghari A, et al. Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem Neurosci. 2021;12(20):3795–2. DOI:10.1021/acschemneuro.1c00477
- Tong JY, Wong A, Zhu D, et al. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020;163(1):3–11.
- Liang F, Wang Y. COVID-19 anosmia: high prevalence, plural neuropathogenic mechanisms, and scarce neurotropism of SARS-CoV-2? Viruses. 2021;13(11). DOI:10.3390/v13112225
- Torabi A, Mohammadbagheri E, Akbari Dilmaghani N, et al. Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chem Neurosci. 2020;11(13):1909–1913. DOI:10.1021/acschemneuro.0c00249
- Cazzolla AP, Lovero R, Lo Muzio L, et al. Taste and smell disorders in COVID-19 patients: role of interleukin-6. ACS Chem Neurosci. 2020;11(17):2774–2781. DOI:10.1021/acschemneuro.0c00447
- Paranhos AC, Ár D, da Silva Lc, et al. Sociodemographic characteristics and comorbidities of patients with long COVID and persistent olfactory dysfunction. JAMA net open. 2022;5(9):e2230637.